E. Blair Clark-Schoeb

E. Blair Clark-Schoeb currently serves as the Chief Communications Officer at GeneDx, a position held since June 2025. Prior to this role, Clark-Schoeb was the Principal at BiotechComm and previously held the title of Chief Communications Officer at Lykos Therapeutics. Extensive experience includes senior leadership positions in communications at Aruvant and Zyla Life Sciences, as well as ownership of BiotechComm, where strategic and tactical programs were developed for biotech, pharmaceutical, and healthcare businesses. Academic credentials include a Master of Healthcare Innovation from the University of Pennsylvania and a degree from Harvard University.